-
1.
公开(公告)号:US07560227B2
公开(公告)日:2009-07-14
申请号:US11365127
申请日:2006-02-28
申请人: Young H. Kim , Ducksoo Kim , Mary Rusckowski
发明人: Young H. Kim , Ducksoo Kim , Mary Rusckowski
CPC分类号: C07K14/47 , C07K7/08 , C07K14/001 , G01N33/573 , G01N33/57484 , G01N2333/908
摘要: The present invention provides compositions suitable for use as biomarkers of vulnerable plaques as well as methods for the use of such compositions. In preferred embodiments, specific molecular imaging agents are provided that permit the selective identification of vulnerable plaques in coronary and other arteries using non-invasive imaging methods. Such specific molecular imaging agents comprise a binding partner linked to a detectable label that can be used in vivo to visualize vulnerable plaques. In certain preferred embodiments, the binding partner is a peptide that binds selectively to a component of a vulnerable plaque. In other preferred embodiments, the binding partner is an antibody that binds selectively to a component of a vulnerable plaque. In other preferred embodiments, the binding partner is a portion of a polypeptide displayed by a bacteriophage that binds selectively to a component of a vulnerable plaque. In preferred embodiments, the component of a vulnerable plaque is myeloperoxidase or a portion thereof.
摘要翻译: 本发明提供适合用作脆弱斑块生物标志物的组合物以及使用这种组合物的方法。 在优选的实施方案中,提供了允许使用非侵入性成像方法在冠状动脉和其他动脉中选择性鉴定易受伤害斑块的特定分子显像剂。 这样的特异性分子显像剂包含与可检测标记连接的结合配偶体,其可以在体内用于使脆弱的斑块可视化。 在某些优选的实施方案中,结合配偶体是选择性地结合易损斑块的组分的肽。 在其它优选的实施方案中,结合配偶体是选择性结合易损斑块组分的抗体。 在其它优选实施方案中,结合配偶体是通过噬菌体展示的多肽展示的部分,所述噬菌体选择性地结合易损斑块的成分。 在优选的实施方案中,脆性斑块的组分是髓过氧化物酶或其一部分。
-
2.
公开(公告)号:US20070207507A1
公开(公告)日:2007-09-06
申请号:US11365127
申请日:2006-02-28
申请人: Young Kim , Ducksoo Kim , Mary Rusckowski
发明人: Young Kim , Ducksoo Kim , Mary Rusckowski
CPC分类号: C07K14/47 , C07K7/08 , C07K14/001 , G01N33/573 , G01N33/57484 , G01N2333/908
摘要: The present invention provides compositions suitable for use as biomarkers of vulnerable plaques as well as methods for the use of such compositions. In preferred embodiments, specific molecular imaging agents are provided that permit the selective identification of vulnerable plaques in coronary and other arteries using non-invasive imaging methods. Such specific molecular imaging agents comprise a binding partner linked to a detectable label that can be used in vivo to visualize vulnerable plaques. In certain preferred embodiments, the binding partner is a peptide that binds selectively to a component of a vulnerable plaque. In other preferred embodiments, the binding partner is an antibody that binds selectively to a component of a vulnerable plaque. In other preferred embodiments, the binding partner is a portion of a polypeptide displayed by a bacteriophage that binds selectively to a component of a vulnerable plaque. In preferred embodiments, the component of a vulnerable plaque is myeloperoxidase or a portion thereof.
摘要翻译: 本发明提供适合用作脆弱斑块生物标志物的组合物以及使用这种组合物的方法。 在优选的实施方案中,提供了允许使用非侵入性成像方法在冠状动脉和其他动脉中选择性鉴定易受伤害斑块的特定分子显像剂。 这样的特异性分子显像剂包含与可检测标记连接的结合配偶体,其可以在体内用于使脆弱的斑块可视化。 在某些优选的实施方案中,结合配偶体是选择性地结合易损斑块的组分的肽。 在其它优选的实施方案中,结合配偶体是选择性结合易损斑块组分的抗体。 在其它优选实施方案中,结合配偶体是通过噬菌体展示的多肽展示的部分,所述噬菌体选择性地结合易损斑块的成分。 在优选的实施方案中,脆性斑块的组分是髓过氧化物酶或其一部分。
-
公开(公告)号:US06899864B2
公开(公告)日:2005-05-31
申请号:US10112094
申请日:2002-04-01
IPC分类号: A61B5/055 , A61K20060101 , A61K31/535 , A61K39/395 , A61K41/00 , A61K45/00 , A61K47/48 , A61K49/08 , A61K51/00 , A61K51/04 , A61K51/10 , A61P35/04 , C07K16/30 , C12P21/08 , C12Q1/68 , A61K3/535
CPC分类号: C07K16/3007 , A61K47/6897 , A61K51/0495 , B82Y5/00
摘要: The present invention provides a kit and a method for targeting of a diagnostic or therapeutic agent to a target site in a mammal having a pathological condition. The kit comprises, in separate containers, (a) a first conjugate comprising a targeting moiety and a Morpholino oligomer, wherein the targeting moiety selectively binds to a primary, target-specific binding site of the target site or to a substance produced by or associated with the target site; (b) optionally, a clearing agent; and (c) a second conjugate comprising a complementary Morpholino oligomer and a diagnostic agent or therapeutic agent. The method comprises administering (a), optionally (b), and (c) to a mammal.
摘要翻译: 本发明提供了具有病理状态的哺乳动物中靶向部位的诊断或治疗剂的靶向试剂盒和方法。 该试剂盒在分开的容器中包含(a)包含靶向部分和吗啉代低聚物的第一缀合物,其中靶向部分选择性地结合到靶位点的原代靶特异性结合位点,或与由 与目标网站; (b)任选的清算代理人; 和(c)包含互补吗啉代低聚物和诊断剂或治疗剂的第二缀合物。 该方法包括向哺乳动物施用(a),任选(b)和(c)。
-
公开(公告)号:US5980861A
公开(公告)日:1999-11-09
申请号:US614078
申请日:1996-03-12
申请人: Donald J. Hnatowich , Mary Rusckowski , George Mardirossian , Paul Winnard, Jr. , Fengchun Chang
发明人: Donald J. Hnatowich , Mary Rusckowski , George Mardirossian , Paul Winnard, Jr. , Fengchun Chang
CPC分类号: A61K51/088 , A61K51/0491 , C07K1/1077 , A61K2123/00
摘要: Compositions of radiolabeled nucleic acids and methods for synthesis and use thereof are disclosed.
摘要翻译: 公开了放射性标记的核酸的组合物及其合成和使用方法。
-
公开(公告)号:US20050255043A1
公开(公告)日:2005-11-17
申请号:US11102191
申请日:2005-04-08
申请人: Donald Hnatowich , Mary Rusckowski
发明人: Donald Hnatowich , Mary Rusckowski
CPC分类号: A61K51/1203
摘要: Labeled bacteriophage are disclosed which are useful for detecting a bacterial infection in vivo.
摘要翻译: 公开了用于检测体内细菌感染的标记噬菌体。
-
公开(公告)号:US5965133A
公开(公告)日:1999-10-12
申请号:US967297
申请日:1997-11-07
申请人: Charles R. Cantor , Christof M. Niemeyer , Cassandra L. Smith , Takeshi Sano , Donald J. Hnatowich , Mary Rusckowski
发明人: Charles R. Cantor , Christof M. Niemeyer , Cassandra L. Smith , Takeshi Sano , Donald J. Hnatowich , Mary Rusckowski
IPC分类号: G01N33/566 , A61K38/00 , A61K38/16 , A61K38/21 , A61K38/22 , A61K38/27 , A61K38/43 , A61K39/00 , A61K39/395 , A61K45/00 , A61K47/48 , A61K49/00 , A61K51/00 , A61K51/12 , A61P31/04 , A61P31/12 , A61P35/00 , A61P35/02 , C03C17/30 , C03C17/34 , C07H21/04 , C12N15/09 , C12Q1/68 , A61K31/70
CPC分类号: B82Y5/00 , A61K47/481 , A61K47/48146 , A61K47/48961 , A61K51/1268 , C03C17/30 , C03C17/3405 , C12Q1/6804 , C12Q1/682 , Y10S977/80 , Y10S977/808 , Y10S977/898 , Y10S977/906 , Y10S977/92
摘要: The invention is directed to constructs and compositions containing multimeric forms of nucleic acid. Multimeric nucleic acids comprise single-stranded nucleic acids attached via biotin to streptavidin and bound with a functional group. These constructs can be utilized in vivo to treat or identify diseased tissue or cells. Repeated administrations of multimeric nucleic acid compositions produce a rapid and specific amplification of nucleic acid constructs and their attached functional groups. For treatment purposes, functional groups may be toxins, radioisotopes, genes or enzymes. Diagnostically, labeled multimeric constructs may be used to identify specific targets in vivo or in vitro. Multimeric nucleic acids may also be used in nanotechnology and to create self-assembling polymeric aggregates such as membranes of defined porosity, microcircuits and many other products.
摘要翻译: 本发明涉及包含核酸的多聚体形式的构建体和组合物。 多聚核酸包含通过生物素与链霉亲和素连接并与官能团结合的单链核酸。 这些构建体可以在体内用于治疗或鉴定患病组织或细胞。 多重核酸组合物的重复施用产生核酸构建体及其连接的官能团的快速和特异性扩增。 为了治疗目的,官能团可以是毒素,放射性同位素,基因或酶。 在诊断上,标记的多聚体构建体可用于在体内或体外鉴定特异性靶标。 多聚核酸也可用于纳米技术,并且可以产生自组装聚合物聚集体,例如确定的孔隙率的膜,微电路和许多其他产物。
-
公开(公告)号:US20110158913A1
公开(公告)日:2011-06-30
申请号:US12009452
申请日:2008-01-18
申请人: Don Hnatowich , Kayoko Nakamura , Yi Wang , Xinrong Liu , Jiang He , Surong Zhang , Mary Rusckowski
发明人: Don Hnatowich , Kayoko Nakamura , Yi Wang , Xinrong Liu , Jiang He , Surong Zhang , Mary Rusckowski
IPC分类号: A61K49/00
CPC分类号: G01N33/582 , A61K49/0032 , A61K49/0054 , G01N33/542 , G01N33/574
摘要: The present invention relates, in part, to detectably labeled oligomer duplexes and their use in optical imaging, including, in vivo optical imaging. The invention includes methods of optical imaging including in vivo pretargeting methods and in vivo antisense optical imaging methods.
摘要翻译: 本发明部分涉及可检测标记的寡聚体双链体及其在光学成像中的应用,包括体内光学成像。 本发明包括光学成像方法,包括体内预靶向方法和体内反义光学成像方法。
-
公开(公告)号:US5561043A
公开(公告)日:1996-10-01
申请号:US189448
申请日:1994-01-31
申请人: Charles R. Cantor , Christof M. Niemeyer , Cassandra L. Smith , Takeshi Sano , Donald J. Hnatowich , Mary Rusckowski
发明人: Charles R. Cantor , Christof M. Niemeyer , Cassandra L. Smith , Takeshi Sano , Donald J. Hnatowich , Mary Rusckowski
IPC分类号: G01N33/566 , A61K38/00 , A61K38/16 , A61K38/21 , A61K38/22 , A61K38/27 , A61K38/43 , A61K39/00 , A61K39/395 , A61K45/00 , A61K47/48 , A61K49/00 , A61K51/00 , A61K51/12 , A61P31/04 , A61P31/12 , A61P35/00 , A61P35/02 , C03C17/30 , C03C17/34 , C07H21/04 , C12N15/09 , C12Q1/68 , C07H21/02
CPC分类号: B82Y5/00 , A61K47/481 , A61K47/48146 , A61K47/48961 , A61K51/1268 , C03C17/30 , C03C17/3405 , C12Q1/6804 , C12Q1/682 , Y10S977/80 , Y10S977/808 , Y10S977/898 , Y10S977/906 , Y10S977/92
摘要: The invention is directed to constructs and compositions containing multimeric forms of nucleic acid. Multimeric nucleic acids comprise single-stranded nucleic acids attached via biotin to streptavidin and bound with a functional group. These constructs can be utilized in vivo to treat or identify diseased tissue or cells. Repeated administrations of multimeric nucleic acid compositions produce a rapid and specific amplification of nucleic acid constructs and their attached functional groups. For treatment purposes, functional groups may be toxins, radioisotopes, genes or enzymes. Diagnostically, labeled multimeric constructs may be used to identify specific targets in vivo or in vitro. Multimeric nucleic acids may also be used in nanotechnology and to create self-assembling polymeric aggregates such as membranes of defined porosity, microcircuits and many other products.
-
-
-
-
-
-
-